20-5302137-C-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting
The NM_144773.4(PROKR2):c.1058G>A(p.Arg353His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000681 in 1,614,144 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_144773.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PROKR2 | ENST00000678254.1 | c.1058G>A | p.Arg353His | missense_variant | Exon 3 of 3 | NM_144773.4 | ENSP00000504128.1 | |||
PROKR2 | ENST00000217270.4 | c.1058G>A | p.Arg353His | missense_variant | Exon 3 of 3 | 1 | ENSP00000217270.3 | |||
PROKR2 | ENST00000678059.1 | c.950G>A | p.Arg317His | missense_variant | Exon 3 of 3 | ENSP00000503366.1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152144Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251478Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135914
GnomAD4 exome AF: 0.0000677 AC: 99AN: 1461882Hom.: 0 Cov.: 32 AF XY: 0.0000550 AC XY: 40AN XY: 727242
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152262Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74466
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2025 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 353 of the PROKR2 protein (p.Arg353His). This variant is present in population databases (rs576243101, gnomAD 0.04%). This missense change has been observed in individual(s) with Kallmann syndrome and/or nonobstructive azoospermia (PMID: 30576231, 36259570). ClinVar contains an entry for this variant (Variation ID: 1012475). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt PROKR2 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects PROKR2 function (PMID: 30576231). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 12, 2022 | Published functional studies demonstrate a damaging effect (Zhao et al., 2019); This variant is associated with the following publications: (PMID: 31748124, 30576231, 30602096, 34636164) - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 25, 2023 | Variant summary: PROKR2 c.1058G>A (p.Arg353His) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 5.2e-05 in 251478 control chromosomes in the gnomAD database and at a frequency of 0.00068, including 72 heterozygotes and one homozygote, in the ToMMo 54KJPN dataset of East Asian control individuals. This frequency suggests the variant is not likely associated with a highly penetrant autosomal dominant condition and may be a benign polymorphism found primarily in individuals of East Asian ancestry. c.1058G>A has been reported in the literature in two Chinese individuals affected with Kallmann Syndrome 3 (Zhao_2019, Men_2020, Wang_2023). One of these individuals also had a variant in the FGFR1 gene which was suggested may contribute to the disease phenotype, possibly in an additive manner as the PROKR2 and FGFR1 variants were each inherited from an unaffected parent (Men_2020). c.1058G>A has also been reported in the heterozygous state as a VUS in an individual with nonobstructive azoospermia who did not have a clinical diagnosis of Kallmann Syndrome (Liu_2023). These data do not allow any conclusion about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function in vitro and found the variant had normal cell surface expression and Gas signaling, but ERK1/2 signaling and Gaq-dependent signaling was decreased to approximately 50% compared to the wild type (Zhao_2019). The following publications have been ascertained in the context of this evaluation (PMID: 36259570, 31748124, 30576231, 36694982). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. One submitter classified the variant as likely pathogenic, and one submitter classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly benign. - |
Hypogonadotropic hypogonadism 3 with or without anosmia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 16, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at